News

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome Provided by GlobeNewswire Jul 7, 2025, 4:00:11 AM ...
Olivia had been showing symptoms since she was just 7 months old — including a belly that remained swollen, hard to the touch ...
A Cork man 'took the chance' last week in getting an ink forecasting Cork to win the All Ireland Senior Hurling Championship, ...
The jersey in question was a special Tipperary top with the Dillon Quirke foundation logo on the centre of the jersey. The ...
Liam Cahill said he "never flinched" on the sideline today because he had Dillon Quirke's name on his chest. The tragic ...
A Sterling family is seeking community support after a "perfectly normal day" changed their lives forever. Jeremy Hunter suffered a severe stroke May 20 that resulted in emergency surgery to remove a ...
Killarney was chosen as the important venue this week by The Dillon Quirke Foundation when it launched its first cardiac ...
In one of the greatest second half performances ever seen in an All-Ireland final Tipperary blew away the Rebels ...
The father of Dillon Quirke, the Tipperary hurler who died after collapsing during a club championship match almost three years ago, has paid tribute to the "magnificent" All-Ireland winning team from ...
“Initiatives like this play an important role in raising awareness about the value of early cardiac screening in helping to prevent Sudden Adult Death Syndrome. We support all young athletes taking ...
MPS-I is a rare, inherited neurometabolic disease caused by a deficiency of the alpha-L-iduronidase (IDUA) lysosomal enzyme resulting in the accumulation of glycosaminoglycans (GAGs) in multiple ...
HYOGO, Japan I July 8, 2025 I JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced that it has entered into a license agreement with Alexion, ...